Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Overall Survival
74%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
64%
95% Confidence Interval
61%
Weight Loss
55%
Cluster Randomized Trial
49%
Breast Cancer Survivors
47%
Pancreatic Cancer
45%
Odds Ratio
43%
Generalized Estimating Equations
42%
Tumor
39%
Clinical Outcomes
37%
Behavioral Weight Loss
36%
Neoadjuvant
34%
Prostate Cancer Risk
34%
Health Studies
34%
Diet Study
34%
NIH-AARP
34%
Recurrent or Metastatic
34%
Quality of Life
34%
Pancreaticoduodenectomy
34%
Pancreatic Ductal Adenocarcinoma
33%
Enhanced Recovery
32%
Good Health
32%
Cancer Patients
30%
Cetuximab
30%
Alzheimer's Disease
30%
Alzheime's Disease
30%
Phase II Trial
28%
Randomized Clinical Trial
27%
Recurrence-free Survival
27%
Obesity
27%
After Surgery
26%
Obese Women
26%
Relative Efficiency
26%
Comorbidity
26%
Nab-paclitaxel
25%
Stepped-wedge Trial
24%
Gemcitabine
23%
Lung
23%
Chemotherapy
23%
Multivariate Analysis
23%
Hazard Ratio
22%
Body Mass Index
21%
Human Papillomavirus
21%
Prognostic Factors
21%
Neoadjuvant Therapy
21%
Lung Transplantation
21%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
20%
Residual Tumor
20%
Locally Advanced
20%
Medicine and Dentistry
Overall Survival
100%
Malignant Neoplasm
83%
Neoplasm
77%
Health Care Cost
55%
Chemotherapy
48%
Odds Ratio
48%
Pancreas Adenocarcinoma
47%
Neuroendocrine Tumor
47%
Pancreaticoduodenectomy
46%
Randomized Controlled Trial
46%
Computer Assisted Tomography
43%
Clinical Trial
42%
Comorbidity
38%
Non Small Cell Lung Cancer
34%
Pancreas Cancer
34%
Recurrent Disease
30%
Radiation Therapy
30%
Breast Cancer
29%
Progression Free Survival
29%
Diseases
28%
Oral
27%
Antimicrobial Agent
27%
Arm
27%
Lung Cancer
26%
Paclitaxel
26%
Gemcitabine
26%
Obesity
26%
Recurrence Free Survival
25%
Biological Marker
24%
Lung
23%
Neoadjuvant Therapy
23%
Multivariate Analysis
22%
Quality of Life
20%
Neoadjuvant Chemotherapy
20%
Logistic Regression Analysis
19%
Tumor
19%
Oncology
19%
Colorectal Carcinoma
19%
Hazard Ratio
19%
Body Mass Index
19%
Surgical Infection
18%
Cesarean Section
18%
Distal Pancreatectomy
18%
Postoperative Complication
18%
Pancreatectomy
18%
Cancer
17%
Lung Transplantation
17%
Acute Myeloid Leukemia
17%
Uterine Cancer
17%
Cetuximab
17%